UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer

Cancer cell, 2005-09, Vol.8 (3), p.227-239

2005

Volltextzugriff (PDF)

Complexity of miR-223 regulation by CEBPA in human AML

Leukemia research, 2010-05, Vol.34 (5), p.672-676

2010

Volltextzugriff (PDF)

Functional interplay of SP family members and nuclear factor Y is essential for transcriptional activation of the human Calreticulin gene

Biochimica et biophysica acta, 2015-09, Vol.1849 (9), p.1188-1197

2015

Volltextzugriff (PDF)

Activation of the unfolded protein response in human acute myeloid leukemia

Methods in enzymology, 2011, Vol.489, p.227

2011

Volltextzugriff (PDF)

Inhibition of tissue transglutaminase sensitizes TRAIL-resistant lung cancer cells through upregulation of death receptor 5

FEBS letters, 2010-07, Vol.584 (13), p.2867-2871

2010

Volltextzugriff (PDF)

Unfolded protein response suppresses CEBPA by induction of calreticulin in acute myeloid leukaemia

Journal of cellular and molecular medicine, 2010-06, Vol.14 (6b), p.1509-1519

2010

Volltextzugriff (PDF)

SCOMP Is Superior to Degenerated Oligonucleotide Primed-Polymerase Chain Reaction for Global Amplification of Minute Amounts of DNA from Microdissected Archival Tissue Samples

The American journal of pathology, 2002-07, Vol.161 (1), p.43-51

2002

Volltextzugriff (PDF)

Der Einsatz von Immuncheckpoint-Inhibitoren im onkologischen Alltag

Zeitschrift für Rheumatologie, 2020-01, Vol.79 (8), p.809-817

Schardt, Julian

2020

Volltextzugriff (PDF)

Somatic CEBPA Mutations Are a Frequent Second Event in Families With Germline CEBPA Mutations and Familial Acute Myeloid Leukemia

Journal of clinical oncology, 2008-11, Vol.26 (31), p.5088-5093

2008

Volltextzugriff (PDF)

Swiss experience of atezolizumab for platinum-pretreated urinary tract carcinoma: the SAUL study in real-world practice

Swiss medical weekly, 2020-05, Vol.150 (1920), p.w20223

2020

Volltextzugriff (PDF)

Sulfobetaine Methacrylate Polymers of Unconventional Polyzwitterion Architecture and Their Antifouling Properties

Biomacromolecules, 2021-04, Vol.22 (4), p.1494-1508

2021

Volltextzugriff (PDF)

Low Fouling Polysulfobetaines with Variable Hydrophobic Content

Macromolecular rapid communications., 2022-06, Vol.43 (12), p.e2100589-n/a

2022

Volltextzugriff (PDF)

Effect of Dipole Orientation in Mixed, Charge-Equilibrated Self-assembled Monolayers on Protein Adsorption and Marine Biofouling

ACS applied materials & interfaces, 2020-11, Vol.12 (45), p.50953-50961

2020

Volltextzugriff (PDF)

Safety and efficacy of perioperative cisplatin/gemcitabine (cis/gem) and durvalumab (durva) for operable muscle-invasive urothelial carcinoma (MIUC): SAKK 06/17

Journal of clinical oncology, 2021-02, Vol.39 (6_suppl), p.430-430

2021

Volltextzugriff (PDF)

Long lasting response to anti-PD-1 therapy of recurrent conjunctival squamous cell carcinoma - A case report and systematic review of the literature

Current problems in cancer. Case reports, 2021-12, Vol.4, p.100088, Article 100088

2021

Volltextzugriff (PDF)

Rhumatologie: Point de contrôle franchi – une nouvelle ère de la rhumatologie?

Forum médical suisse (En ligne), 2018-12

2018

Volltextzugriff (PDF)

Perioperative chemoimmunotherapy with durvalumab (Durva) in combination with cisplatin/gemcitabine (Cis/Gem) for operable muscle-invasive urothelial carcinoma (MIUC): Preplanned interim analysis of a single-arm phase II trial (SAKK 06/17)

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.499-499

2020

Volltextzugriff (PDF)

Das anorektale Melanom

Forum médical suisse (En ligne), 2016-02, Vol.16 (8)

2016

Volltextzugriff (PDF)

1 – 18 von 18

Suche als RSS-Feed

Aktive Filter

KollektionNature Journals

Zeitschrift / SerieBlood

ThemaAntineoplastic Agents - Therapeutic Use

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(18)

Sprache

Englisch
(16)
Französisch
(2)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer

Complexity of miR-223 regulation by CEBPA in human AML

Functional interplay of SP family members and nuclear factor Y is essential for transcriptional activation of the human Calreticulin gene

Activation of the unfolded protein response in human acute myeloid leukemia

Inhibition of tissue transglutaminase sensitizes TRAIL-resistant lung cancer cells through upregulation of death receptor 5

Unfolded protein response suppresses CEBPA by induction of calreticulin in acute myeloid leukaemia

SCOMP Is Superior to Degenerated Oligonucleotide Primed-Polymerase Chain Reaction for Global Amplification of Minute Amounts of DNA from Microdissected Archival Tissue Samples

Der Einsatz von Immuncheckpoint-Inhibitoren im onkologischen Alltag

Somatic CEBPA Mutations Are a Frequent Second Event in Families With Germline CEBPA Mutations and Familial Acute Myeloid Leukemia

Swiss experience of atezolizumab for platinum-pretreated urinary tract carcinoma: the SAUL study in real-world practice

Sulfobetaine Methacrylate Polymers of Unconventional Polyzwitterion Architecture and Their Antifouling Properties

Low Fouling Polysulfobetaines with Variable Hydrophobic Content

Effect of Dipole Orientation in Mixed, Charge-Equilibrated Self-assembled Monolayers on Protein Adsorption and Marine Biofouling

Safety and efficacy of perioperative cisplatin/gemcitabine (cis/gem) and durvalumab (durva) for operable muscle-invasive urothelial carcinoma (MIUC): SAKK 06/17

Long lasting response to anti-PD-1 therapy of recurrent conjunctival squamous cell carcinoma - A case report and systematic review of the literature

Rhumatologie: Point de contrôle franchi – une nouvelle ère de la rhumatologie?

Perioperative chemoimmunotherapy with durvalumab (Durva) in combination with cisplatin/gemcitabine (Cis/Gem) for operable muscle-invasive urothelial carcinoma (MIUC): Preplanned interim analysis of a single-arm phase II trial (SAKK 06/17)

Das anorektale Melanom

Aktive Filter

Suchergebnisse filtern